KEILAH FORD: Open Payments
NPI 1871980730 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$619 in 12 payments from 6 companies in 2025. Trend: 2023 $680 · 2024 $293 · 2025 $619
Food & beverage: $619
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 1 | $189 |
| Axsome Therapeutics, Inc. | 2 | $150 |
| ViiV Healthcare Company | 1 | $119 |
| ABBVIE INC. | 5 | $99 |
| Otsuka America Pharmaceutical, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: NEFFY, Auvelity, VRAYLAR, REXULTI, ABILIFY MAINTENA, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
